• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿激酶受体占据对人肿瘤细胞纤溶酶生成及基底膜蛋白水解的影响。

Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells.

作者信息

Cohen R L, Xi X P, Crowley C W, Lucas B K, Levinson A D, Shuman M A

机构信息

Cancer Research Institute, University of California-San Francisco 94143.

出版信息

Blood. 1991 Jul 15;78(2):479-87.

PMID:1648983
Abstract

The goal of the present study was to assess the relative importance of receptor-bound and secreted plasminogen activator urokinase (u-PA) in generating cell-surface plasmin and fostering destruction of normal tissue by tumor cells. We first showed that active site-inhibited u-PA could displace endogenous u-PA from the surface of the human colon adenocarcinoma cell line HCT 116. We then prepared expression vectors for u-PA and for a mutant molecule in which the codon for the active site serine residue was changed to encode alanine. Expression of non-functional mutant u-PA decreased the level of cell-bound active u-PA by more than 95% via a mechanism that involved competition for receptor sites. Decreased cell-surface u-PA activity was associated with a decrease in cell-bound plasmin activity to undetectable levels, suggesting that receptor-bound u-PA plays an important role in the generation of plasmin on the cell surface. Transfectants that secreted eightfold to 20-fold elevated levels of active wild-type u-PA showed approximately 50% increases in cell-associated u-PA and only twofold to fourfold increases in cell-associated plasmin, suggesting that the role of secreted u-PA in generating cell-surface plasmin activity was relatively minor. In parent cells and both types of transfectants there was a good correlation between the amount of plasmin bound to the tumor cell surface and the extent to which a basement membrane substrate was degraded. These studies show that receptor-bound u-PA provides an efficient mechanism for plasmin generation on the surface of tumor cells, which, in turn, contributes significantly to their degradative potential.

摘要

本研究的目的是评估受体结合型和分泌型纤溶酶原激活物尿激酶(u-PA)在产生细胞表面纤溶酶以及促进肿瘤细胞破坏正常组织方面的相对重要性。我们首先表明,活性位点被抑制的u-PA能够从人结肠腺癌细胞系HCT 116的表面置换内源性u-PA。然后,我们制备了u-PA和一种突变分子的表达载体,其中活性位点丝氨酸残基的密码子被改变以编码丙氨酸。无功能突变型u-PA的表达通过一种涉及受体位点竞争的机制,使细胞结合的活性u-PA水平降低了95%以上。细胞表面u-PA活性的降低与细胞结合的纤溶酶活性降低至无法检测的水平相关,这表明受体结合型u-PA在细胞表面纤溶酶的产生中起重要作用。分泌的活性野生型u-PA水平升高8至20倍的转染细胞显示,细胞相关的u-PA增加了约50%,而细胞相关的纤溶酶仅增加了2至4倍,这表明分泌型u-PA在产生细胞表面纤溶酶活性方面的作用相对较小。在亲本细胞和两种类型的转染细胞中,与肿瘤细胞表面结合的纤溶酶量与基底膜底物被降解的程度之间存在良好的相关性。这些研究表明,受体结合型u-PA为肿瘤细胞表面纤溶酶的产生提供了一种有效的机制,这反过来又对其降解潜能有显著贡献。

相似文献

1
Effects of urokinase receptor occupancy on plasmin generation and proteolysis of basement membrane by human tumor cells.尿激酶受体占据对人肿瘤细胞纤溶酶生成及基底膜蛋白水解的影响。
Blood. 1991 Jul 15;78(2):479-87.
2
Characterization of the binding of urokinase-type plasminogen activator (u-PA) to plasminogen, to plasminogen-activator inhibitor-1 and to the u-PA receptor.尿激酶型纤溶酶原激活剂(u-PA)与纤溶酶原、纤溶酶原激活剂抑制剂-1及u-PA受体结合的特性
Eur J Biochem. 1994 Sep 1;224(2):567-74. doi: 10.1111/j.1432-1033.1994.00567.x.
3
Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants.人肉瘤细胞上尿激酶原和纤溶酶原的激活:一个具有表面结合反应物的蛋白水解系统。
J Cell Biol. 1989 May;108(5):1987-95. doi: 10.1083/jcb.108.5.1987.
4
Generation of cell surface-bound plasmin by cell-associated urokinase-type or secreted tissue-type plasminogen activator: a key event in melanoma cell invasiveness in vitro.细胞相关的尿激酶型或分泌的组织型纤溶酶原激活剂产生细胞表面结合的纤溶酶:体外黑色素瘤细胞侵袭的关键事件。
Exp Cell Res. 1992 Apr;199(2):179-90. doi: 10.1016/0014-4827(92)90423-6.
5
Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase.由纤维蛋白特异性抗体的单链Fv片段和单链尿激酶组成的单链嵌合纤溶酶原激活剂的生化特性
Eur J Biochem. 1992 Dec 15;210(3):945-52. doi: 10.1111/j.1432-1033.1992.tb17499.x.
6
Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.通过对赖氨酸158、异亮氨酸159和异亮氨酸160进行位点特异性诱变获得的重组单链尿激酶型纤溶酶原激活剂突变体的结构和功能表征。
Eur J Biochem. 1988 Nov 15;177(3):575-82. doi: 10.1111/j.1432-1033.1988.tb14409.x.
7
Differential regulation of plasminogen activation in normal keratinocytes and SCC-4 cells by fibroblasts.成纤维细胞对正常角质形成细胞和SCC-4细胞中纤溶酶原激活的差异调节。
J Invest Dermatol. 1995 Mar;104(3):374-8. doi: 10.1111/1523-1747.ep12665844.
8
Prourokinase activation on the surface of human rhabdomyosarcoma cells: localization and inactivation of newly formed urokinase-type plasminogen activator by recombinant class 2 plasminogen activator inhibitor.人横纹肌肉瘤细胞表面的纤溶酶原激活物原激活:重组2类纤溶酶原激活物抑制剂对新形成的尿激酶型纤溶酶原激活物的定位和失活作用
Proc Natl Acad Sci U S A. 1990 Mar;87(6):2230-4. doi: 10.1073/pnas.87.6.2230.
9
Identification and characterization of human endothelial cell membrane binding sites for tissue plasminogen activator and urokinase.组织型纤溶酶原激活剂和尿激酶的人内皮细胞膜结合位点的鉴定与特性分析
J Biol Chem. 1990 Feb 15;265(5):2908-16.
10
Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells.肿瘤坏死因子可诱导人内皮细胞产生尿激酶型纤溶酶原激活物。
Blood. 1990 May 15;75(10):1991-8.

引用本文的文献

1
Expression of the inhibitory Ly49E receptor is not critically involved in the immune response against cutaneous, pulmonary or liver tumours.抑制性Ly49E受体的表达在针对皮肤、肺部或肝脏肿瘤的免疫反应中并非关键因素。
Sci Rep. 2016 Jul 29;6:30564. doi: 10.1038/srep30564.
2
Heat shock proteins HSP70 and MRJ cooperatively regulate cell adhesion and migration through urokinase receptor.热休克蛋白HSP70和MRJ通过尿激酶受体协同调节细胞黏附和迁移。
BMC Cancer. 2014 Aug 30;14:639. doi: 10.1186/1471-2407-14-639.
3
Advantages of the AMDL-ELISA DR-70 (FDP) assay over carcinoembryonic antigen (CEA) for monitoring colorectal cancer patients.
与癌胚抗原(CEA)相比,AMDL-ELISA DR-70(FDP)检测法在监测结直肠癌患者方面的优势。
J Immunoassay Immunochem. 2010;31(2):131-47. doi: 10.1080/15321811003617438.
4
Tumor and vascular targeting of a novel oncolytic measles virus retargeted against the urokinase receptor.一种新型溶瘤麻疹病毒靶向尿激酶受体的肿瘤及血管靶向作用
Cancer Res. 2009 Feb 15;69(4):1459-68. doi: 10.1158/0008-5472.CAN-08-2628. Epub 2009 Feb 10.
5
Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.尿激酶型纤溶酶原激活物受体表达的下调抑制了Erk信号传导,同时由于结肠癌细胞中uPAR-β1整合素复合物的缺失而抑制了侵袭性。
Br J Cancer. 2003 Jul 21;89(2):374-84. doi: 10.1038/sj.bjc.6601098.
6
Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity.被占据的尿激酶受体(uPAR)与低密度脂蛋白受体相关蛋白的直接结合是uPAR内吞作用和细胞表面尿激酶活性调节所必需的。
Mol Biol Cell. 2001 May;12(5):1467-79. doi: 10.1091/mbc.12.5.1467.
7
Plasminogen activator system, vascular endothelial growth factor, and colorectal cancer progression.纤溶酶原激活物系统、血管内皮生长因子与结直肠癌进展
Mol Pathol. 2000 Dec;53(6):307-12. doi: 10.1136/mp.53.6.307.
8
Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner.肌球蛋白轻链激酶在Ras/ERK下游发挥作用,以整合素选择性方式促进尿激酶型纤溶酶原激活剂刺激的细胞迁移。
J Cell Biol. 1999 Jul 12;146(1):149-64. doi: 10.1083/jcb.146.1.149.
9
Urokinase type plasminogen activator receptor expression in colorectal neoplasms.尿激酶型纤溶酶原激活物受体在结直肠肿瘤中的表达
Gut. 1998 Dec;43(6):798-805. doi: 10.1136/gut.43.6.798.
10
Significance of plasminogen activator inhibitor 2 as a prognostic marker in primary lung cancer: association of decreased plasminogen activator inhibitor 2 with lymph node metastasis.纤溶酶原激活物抑制剂2作为原发性肺癌预后标志物的意义:纤溶酶原激活物抑制剂2降低与淋巴结转移的关联
Br J Cancer. 1998 Sep;78(6):833-9. doi: 10.1038/bjc.1998.588.